118 related articles for article (PubMed ID: 2171581)
41. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides. II. Increased susceptibility to fatal pneumococcal sepsis due to absence of anti-polysaccharide IgG3 is corrected by induction of anti-polysaccharide IgG1.
McLay J; Leonard E; Petersen S; Shapiro D; Greenspan NS; Schreiber JR
J Immunol; 2002 Apr; 168(7):3437-43. PubMed ID: 11907102
[TBL] [Abstract][Full Text] [Related]
42. The role of capsular polysaccharide K21b of Klebsiella and of the structurally related colanic-acid polysaccharide of Escherichia coli in resistance to phagocytosis and serum killing.
Allen PM; Fisher D; Saunders JR; Hart CA
J Med Microbiol; 1987 Dec; 24(4):363-70. PubMed ID: 3320374
[TBL] [Abstract][Full Text] [Related]
43. Three surface exoglycosidases from Streptococcus pneumoniae, NanA, BgaA, and StrH, promote resistance to opsonophagocytic killing by human neutrophils.
Dalia AB; Standish AJ; Weiser JN
Infect Immun; 2010 May; 78(5):2108-16. PubMed ID: 20160017
[TBL] [Abstract][Full Text] [Related]
44. Human Intelectin-1 Promotes Cellular Attachment and Neutrophil Killing of Streptococcus pneumoniae in a Serotype-Dependent Manner.
Andresen S; Fantone K; Chapla D; Rada B; Moremen KW; Pierce M; Szymanski CM
Infect Immun; 2022 May; 90(5):e0068221. PubMed ID: 35499339
[TBL] [Abstract][Full Text] [Related]
45. Emergence of antibody to capsular polysaccharides of Streptococcus pneumoniae during outbreaks of pneumonia: association with nasopharyngeal colonization.
Musher DM; Groover JE; Reichler MR; Riedo FX; Schwartz B; Watson DA; Baughn RE; Breiman RF
Clin Infect Dis; 1997 Mar; 24(3):441-6. PubMed ID: 9114197
[TBL] [Abstract][Full Text] [Related]
46. In vitro, Candida albicans releases the immune modulator adenosine and a second, high-molecular weight agent that blocks neutrophil killing.
Smail EH; Cronstein BN; Meshulam T; Esposito AL; Ruggeri RW; Diamond RD
J Immunol; 1992 Jun; 148(11):3588-95. PubMed ID: 1316920
[TBL] [Abstract][Full Text] [Related]
47. Antibody to capsular polysaccharide of Streptococcus pneumoniae at the time of hospital admission for Pneumococcal pneumonia.
Musher DM; Phan HM; Watson DA; Baughn RE
J Infect Dis; 2000 Jul; 182(1):158-67. PubMed ID: 10882593
[TBL] [Abstract][Full Text] [Related]
48. Role of Shigella dysenteriae type 1 slime polysaccharide in resistance to serum killing and phagocytosis.
Qadri F; Haque MA; Hossain A; Azim T; Alam K; Albert MJ
Microb Pathog; 1993 Jun; 14(6):441-9. PubMed ID: 8412617
[TBL] [Abstract][Full Text] [Related]
49. Interaction of ceftriaxone with human polymorphonuclear neutrophil function.
Labro MT; Babin-Chevaye C; Pochet I; Hakim J
J Antimicrob Chemother; 1987 Dec; 20(6):849-55. PubMed ID: 2831183
[TBL] [Abstract][Full Text] [Related]
50. Trivalent pneumococcal protein recombinant vaccine protects against lethal Streptococcus pneumoniae pneumonia and correlates with phagocytosis by neutrophils during early pathogenesis.
Xu Q; Surendran N; Verhoeven D; Klapa J; Ochs M; Pichichero ME
Vaccine; 2015 Feb; 33(8):993-1000. PubMed ID: 25597944
[TBL] [Abstract][Full Text] [Related]
51. Increasing opsonizing and killing effect of serum from patients with recurrent K1 Klebsiella pneumoniae liver abscess.
Yeh FC; Yeh KM; Siu LK; Fung CP; Yang YS; Lin JC; Chang FY
J Microbiol Immunol Infect; 2012 Apr; 45(2):141-6. PubMed ID: 22444545
[TBL] [Abstract][Full Text] [Related]
52. Inflammatory cytokine (interleukin 6 and tumour necrosis factor alpha) release in a human whole blood system in response to Streptococcus pneumoniae serotype 14 and its capsular polysaccharide.
Jagger MP; Huo Z; Riches PG
Clin Exp Immunol; 2002 Dec; 130(3):467-74. PubMed ID: 12452837
[TBL] [Abstract][Full Text] [Related]
53. [An immunoenzymatic test for IgG antibody levels against 10 serotypes of Streptococcus pneumoniae].
Leal-Esteban LC; Rojas JL; Jaimes AL; Montoya JD; Montoya NE; Leiva L; Trujillo-Vargas CM
Biomedica; 2012; 32(1):92-102. PubMed ID: 23235791
[TBL] [Abstract][Full Text] [Related]
54. In vivo humoral immune responses to isolated pneumococcal polysaccharides are dependent on the presence of associated TLR ligands.
Sen G; Khan AQ; Chen Q; Snapper CM
J Immunol; 2005 Sep; 175(5):3084-91. PubMed ID: 16116197
[TBL] [Abstract][Full Text] [Related]
55. Binding and agglutination of Streptococcus pneumoniae by human surfactant protein D (SP-D) vary between strains, but SP-D fails to enhance killing by neutrophils.
Jounblat R; Kadioglu A; Iannelli F; Pozzi G; Eggleton P; Andrew PW
Infect Immun; 2004 Feb; 72(2):709-16. PubMed ID: 14742512
[TBL] [Abstract][Full Text] [Related]
56. C-reactive protein reactivity with complement and effects on phagocytosis.
Mold C; Du Clos TW; Nakayama S; Edwards KM; Gewurz H
Ann N Y Acad Sci; 1982; 389():251-62. PubMed ID: 7046579
[TBL] [Abstract][Full Text] [Related]
57. The Alpha-Tocopherol Form of Vitamin E Boosts Elastase Activity of Human PMNs and Their Ability to Kill
Bou Ghanem EN; Lee JN; Joma BH; Meydani SN; Leong JM; Panda A
Front Cell Infect Microbiol; 2017; 7():161. PubMed ID: 28516066
[TBL] [Abstract][Full Text] [Related]
58. Rapid microassays of phagocytosis, bacterial killing, superoxide and hydrogen peroxide production by human neutrophils in vitro.
Rajkovic IA; Williams R
J Immunol Methods; 1985 Apr; 78(1):35-47. PubMed ID: 2984293
[TBL] [Abstract][Full Text] [Related]
59. Staphylococcus aureus capsular polysaccharide types 5 and 8 reduce killing by bovine neutrophils in vitro.
Kampen AH; Tollersrud T; Lund A
Infect Immun; 2005 Mar; 73(3):1578-83. PubMed ID: 15731056
[TBL] [Abstract][Full Text] [Related]
60. Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis.
Rajkovic IA; Williams R
Hepatology; 1986; 6(2):252-62. PubMed ID: 3007318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
